182 related articles for article (PubMed ID: 3342099)
1. Adenosine metabolism in human whole blood. Effects of nucleoside transport inhibitors and phosphate concentration.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1988 Feb; 37(4):621-6. PubMed ID: 3342099
[TBL] [Abstract][Full Text] [Related]
2. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
Dawicki DD; Agarwal KC; Parks RE
Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
[TBL] [Abstract][Full Text] [Related]
4. Transport and metabolism of adenosine in human erythrocytes: effect of transport inhibitors and regulation by phosphate.
Plagemann PG
J Cell Physiol; 1986 Sep; 128(3):491-500. PubMed ID: 3488996
[TBL] [Abstract][Full Text] [Related]
5. Significance of plasma adenosine in the antiplatelet activity of forskolin: potentiation by dipyridamole and dilazep.
Agarwal KC; Zielinski BA; Maitra RS
Thromb Haemost; 1989 Feb; 61(1):106-10. PubMed ID: 2749584
[TBL] [Abstract][Full Text] [Related]
6. Characterization of inhibitor-sensitive and -resistant adenosine transporters in cultured human fetal astrocytes.
Gu JG; Nath A; Geiger JD
J Neurochem; 1996 Sep; 67(3):972-7. PubMed ID: 8752102
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
Cass CE; King KM; MontaƱo JT; Janowska-Wieczorek A
Cancer Res; 1992 Nov; 52(21):5879-86. PubMed ID: 1394215
[TBL] [Abstract][Full Text] [Related]
8. Transport and metabolism of 9-beta-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzylthioinosine-sensitive and -insensitive influx.
Prus KL; Averett DR; Zimmerman TP
Cancer Res; 1990 Mar; 50(6):1817-21. PubMed ID: 2306735
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nucleoside and nucleobase transport and nitrobenzylthioinosine binding by dilazep and hexobendine.
Plagemann PG; Kraupp M
Biochem Pharmacol; 1986 Aug; 35(15):2559-67. PubMed ID: 3741459
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside transport in rat cerebral-cortical synaptosomes. Evidence for two types of nucleoside transporters.
Lee CW; Jarvis SM
Biochem J; 1988 Jan; 249(2):557-64. PubMed ID: 3342028
[TBL] [Abstract][Full Text] [Related]
11. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
SenGupta DJ; Unadkat JD
Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glucose uptake in murine cardiomyocyte cell line HL-1 by cardioprotective drugs dilazep and dipyridamole.
Shuralyova I; Tajmir P; Bilan PJ; Sweeney G; Coe IR
Am J Physiol Heart Circ Physiol; 2004 Feb; 286(2):H627-32. PubMed ID: 14551048
[TBL] [Abstract][Full Text] [Related]
13. Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1.
Endres CJ; Sengupta DJ; Unadkat JD
Biochem J; 2004 May; 380(Pt 1):131-7. PubMed ID: 14759222
[TBL] [Abstract][Full Text] [Related]
14. Transport of deoxycoformycin in human erythrocytes. Measurement by adenosine deaminase titration and radioisotope assays.
Chen SF; Stoeckler JD; Parks RE
Biochem Pharmacol; 1984 Dec; 33(24):4069-79. PubMed ID: 6334522
[TBL] [Abstract][Full Text] [Related]
15. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
Plagemann PG; Woffendin C
Biochim Biophys Acta; 1988 Apr; 969(1):1-8. PubMed ID: 3349106
[TBL] [Abstract][Full Text] [Related]
16. Induction of nucleoside transport sites into the host cell membrane of Babesia bovis infected erythrocytes.
Gero AM
Mol Biochem Parasitol; 1989 Jul; 35(3):269-76. PubMed ID: 2747745
[TBL] [Abstract][Full Text] [Related]
17. Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes.
Kalsi KK; Smolenski RT; Yacoub MH
Mol Cell Biochem; 1998 Mar; 180(1-2):193-9. PubMed ID: 9546646
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial action of nitrobenzylthioinosine in combination with purine nucleoside antimetabolites.
Gero AM; Scott HV; O'Sullivan WJ; Christopherson RI
Mol Biochem Parasitol; 1989 Apr; 34(1):87-97. PubMed ID: 2651920
[TBL] [Abstract][Full Text] [Related]
19. Nucleoside transport inhibition and fMLP-stimulated whole blood luminescence.
Ver Donck KL; Verheyen WJ; Van Belle H
J Mol Cell Cardiol; 1991 Jul; 23(7):783-5. PubMed ID: 1791629
[TBL] [Abstract][Full Text] [Related]
20. Hypoxanthine enters human vascular endothelial cells (ECV 304) via the nitrobenzylthioinosine-insensitive equilibrative nucleoside transporter.
Osses N; Pearson JD; Yudilevich DL; Jarvis SM
Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):843-8. PubMed ID: 8760371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]